Featured Research

from universities, journals, and other organizations

Toward simplifying treatment of a serious eye infection

Date:
May 7, 2010
Source:
American Chemical Society
Summary:
Scientists are reporting development of a potential new way of enabling patients with bacterial keratitis to stick with the extraordinarily intensive treatment needed for this potentially blinding eye infection. The disease affects more than 500,000 people each year worldwide, including 30,000 people in the United States.

Scientists are reporting development of a potential new way of enabling patients with bacterial keratitis to stick with the extraordinarily intensive treatment needed for this potentially blinding eye infection. The disease affects more than 500,000 people each year worldwide, including 30,000 people in the United States.

The study is in ACS' Molecular Pharmaceutics, a bi-monthly journal.

Howida Kamal Ibrahim and colleagues explain that bacterial keratitis is a rapidly-progressing infection of the cornea, the clear tissue covering the front of the eye. Treatment method requires that patients frequently use antibiotic eye medicine -- one drop every 5 minutes to start and then more drops every 15-30 minutes for up to 3 days -- and daily use of anti-inflammatory drugs. This intensive treatment regimen is difficult for patients to follow and often requires putting them into a hospital to assure they get adequate treatment.

The scientists describe the development of a new two-in-one formula that combines the antibiotic and anti-inflammatory drug into a single medication. The eye drops contain nano-sized particles -- each about 1/50,000th the width of a human hair -- of an antibiotic (gatifloxacin) and an anti-inflammatory drug (prednisolone) coated with a substance that keeps the medicine in the eye longer. In tests with lab animals, the drops delivered five times more medication to the eye and it remained there three times longer than existing medicine, the scientists say. For patients, the new drops could mean an easier course of treatment that can be done more often out-of-hospital.


Story Source:

The above story is based on materials provided by American Chemical Society. Note: Materials may be edited for content and length.


Journal Reference:

  1. Howida Kamal Ibrahim, Iman Sadar El-Leithy, Amna Awad Makky. Mucoadhesive Nanoparticles as Carrier Systems for Prolonged Ocular Delivery of Gatifloxacin/Prednisolone Bitherapy. Molecular Pharmaceutics, 2010; 7 (2): 576 DOI: 10.1021/mp900279c

Cite This Page:

American Chemical Society. "Toward simplifying treatment of a serious eye infection." ScienceDaily. ScienceDaily, 7 May 2010. <www.sciencedaily.com/releases/2010/05/100505113253.htm>.
American Chemical Society. (2010, May 7). Toward simplifying treatment of a serious eye infection. ScienceDaily. Retrieved October 21, 2014 from www.sciencedaily.com/releases/2010/05/100505113253.htm
American Chemical Society. "Toward simplifying treatment of a serious eye infection." ScienceDaily. www.sciencedaily.com/releases/2010/05/100505113253.htm (accessed October 21, 2014).

Share This



More Health & Medicine News

Tuesday, October 21, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

How Nigeria Beat Its Ebola Outbreak

How Nigeria Beat Its Ebola Outbreak

Newsy (Oct. 20, 2014) The World Health Organization has declared Nigeria free of Ebola. Health experts credit a bit of luck and the government's initial response. Video provided by Newsy
Powered by NewsLook.com
Another Study Suggests Viagra Is Good For The Heart

Another Study Suggests Viagra Is Good For The Heart

Newsy (Oct. 20, 2014) An ingredient in erectile-dysfunction medications such as Viagra could improve heart function. Perhaps not surprising, given Viagra's history. Video provided by Newsy
Powered by NewsLook.com
Ebola Worries End for Dozens on U.S. Watch Lists

Ebola Worries End for Dozens on U.S. Watch Lists

Reuters - US Online Video (Oct. 20, 2014) Forty-three people who had contact with Thomas Eric Duncan, the first person diagnosed with Ebola in the U.S., were cleared overnight of twice-daily monitoring after 21 days of showing no symptoms. Rough Cut (no reporter narration). Video provided by Reuters
Powered by NewsLook.com
CDC Calls for New Ebola Safety Guidelines

CDC Calls for New Ebola Safety Guidelines

AP (Oct. 20, 2014) Centers for Disease Control and Prevention Director Dr. Tom Frieden laid out new guidelines for health care workers when dealing with the deadly Ebola virus including new precautions when taking off personal protective equipment. (Oct. 20) Video provided by AP
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:

Strange & Offbeat Stories


Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins